GREY:TBPMQ - Post by User
Post by
Golddetectoron Oct 28, 2021 7:08pm
226 Views
Post# 34061206
Reduvo approval
Reduvo approval Beside revenue generation, ppl will start looking at tetra more a pharma. A big jump in sp is expected once the announcement comes in the next couple of months. Fda already approved this beside other countries. Tetra also doing adverse same drug but different naming in the us. below details
Dronabinol is marketed as Marinol and Syndros,[20] a registered trademark of Solvay Pharmaceuticals. Dronabinol is also marketed, sold, and distributed by PAR Pharmaceutical Companies under the terms of a license and distribution agreement with SVC pharma LP, an affiliate of Rhodes Technologies for Marinol and Insys Pharmaceuticals for Syndros.[citation needed] Dronabinol is available as a prescription drug (under Marinol and Syndros [21]) in several countries including the United States, Germany, South Africa and Australia.[22] In Canada, Tetra Bio-Pharma filed a New Drug Submission (NDS) with Health Canada for its Dronabinol Soft Gel capsules to be marketed as REDUVO™.[23] Tetra has two other dronabinol drugs with new routes of administration which limit first-pass metabolism; an inhaled THC-based dronabinol drug and their mucoadhesive-delivery dronabinol drug Adversa®, which are both in the accelerated 505(b)(2) New Drug Application (NDA) pathway for the U.S. and Canadian markets.[24]
more detail can be found in link below
https://en.wikipedia.org/wiki/Dronabinol